Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Psychosis”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Not applicableLooking for participantsNCT05945602
What this trial is testing

Neurophysiologic Biomarkers for Cognitive Rehabilitation

Who this might be right for
Schizophrenia Spectrum Disorders
VA Office of Research and Development 80
Not applicableUnknownNCT00627029
What this trial is testing

Evaluation of Programs of Coordinated Care and Disease Management

Who this might be right for
Congestive Heart FailureDiabetesCoronary Artery Disease+6 more
Mathematica Policy Research, Inc. 18,277
Not applicableStudy completedNCT03348787
What this trial is testing

Behavioral and Cognitive Therapies for Auditory Hallucination Management

Who this might be right for
Chronic Psychosis
University Hospital, Toulouse 55
Early research (Phase 1)Not Yet RecruitingNCT06644573
What this trial is testing

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

Who this might be right for
Chronic InsomniaSleep DeprivationREM Behavior Disorder+34 more
Nyree Penn 100
Not applicableStudy completedNCT02451670
What this trial is testing

Reducing Cardiovascular Risk in Adults With Serious Mental Illness

Who this might be right for
Chronic DiseaseMental DisorderHealth Behavior+2 more
HealthPartners Institute 10,347
Testing effectiveness (Phase 2)Study completedNCT00505765
What this trial is testing

Study of NAP (AL-108) in Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 63
Not applicableStudy completedNCT02390557
What this trial is testing

Persons With Disabilities Generating Quality Metrics

Who this might be right for
Physical DisabilityChronic Mental Disorder
Massachusetts General Hospital 451
Large-scale testing (Phase 3)Study completedNCT00789698
What this trial is testing

Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
Sumitomo Pharma America, Inc. 240
Not applicableStudy completedNCT01801787
What this trial is testing

Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia

Who this might be right for
Auditory Verbal HallucinationsSchizophrenia
Charite University, Berlin, Germany 30
Large-scale testing (Phase 3)Study completedNCT04327843
What this trial is testing

Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)

Who this might be right for
SchizophreniaMedication NonadherenceSchizo Affective Disorder
Case Western Reserve University 22
Not applicableUnknownNCT03476473
What this trial is testing

Early Detection of Respiratory Disorders in Psychosis

Who this might be right for
SchizophreniaPsychosisChronic Respiratory Disease
Fundación Marques de Valdecilla 200
Testing effectiveness (Phase 2)Study completedNCT00480571
What this trial is testing

Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
BioLineRx, Ltd. 90
Early research (Phase 1)Study completedNCT01592110
What this trial is testing

A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Zogenix, Inc. 40
Post-approval studies (Phase 4)Ended earlyNCT00232349
What this trial is testing

Efficacy of Galantamine to Treat Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorder
Seattle Institute for Biomedical and Clinical Research 21
Not applicableStudy completedNCT02029989
What this trial is testing

Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

Who this might be right for
HyperlipidemiaDiabetesHypertension
University of Minnesota 121
Large-scale testing (Phase 3)Study completedNCT00843687
What this trial is testing

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Not applicableUnknownNCT00192582
What this trial is testing

AIMHI NT Relapse Prevention Trial

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychoses, Substance Induced+2 more
Menzies School of Health Research 90
Not applicableStudy completedNCT04503954
What this trial is testing

Efficacy of Chronic Disease Self-management Program in People With Schizophrenia

Who this might be right for
Schizophrenia
National Taipei University of Nursing and Health Sciences 80
Not applicableStudy completedNCT01487668
What this trial is testing

Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders

Who this might be right for
Bipolar DisorderSchizophreniaMajor Depressive Disorder+2 more
VA Office of Research and Development 304
Large-scale testing (Phase 3)Study completedNCT00228462
What this trial is testing

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Who this might be right for
Schizophrenia
AstraZeneca 197
Next Page